ECE-2 Antibody [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # AF1645I
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Janelia Fluor 549
Antibody Source
Polyclonal Goat IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human ECE-2
Gly104-Trp787
Accession # EAW78275
Gly104-Trp787
Accession # EAW78275
Specificity
Detects human ECE-2 in direct ELISAs and Western blots. In direct ELISAs and Western blots, approximately 5% cross-reactivity with recombinant human ECE-1 is observed.
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Applications for ECE-2 Antibody [Janelia Fluor® 549]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ECE-2
Long Name
Endothelin-converting Enzyme-2
Alternate Names
ECE2
Gene Symbol
ECE2
Additional ECE-2 Products
Product Documents for ECE-2 Antibody [Janelia Fluor® 549]
Product Specific Notices for ECE-2 Antibody [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...